Tumor immunotherapies, especially those leveraging T-cells to identify and eliminate cancer cells, represent a major ...

Engineered bacteria reprogram tumor macrophages and direct copper into cancer cells, triggering cell death and systemic immunity without damaging healthy tissue.

Fred Hutch Cancer Center — an organization responsible for transforming cancer treatment and helping establish Seattle's ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on ...

The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors.

On 15 August 2025, Artiva Biotherapeutics Inc. announced a phase 2a study to evaluate the safety and efficacy of AlloNK®, an ...

Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it ...

A Northwestern Medicine study has uncovered new insights that may aid in understanding and potentially treating one of the ...

A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but ...

Breast cancer is one of the most common cancers among American women. It is estimated that within the United States, about ...

Chinese scientists have developed a new method that enhances tumor immunotherapy, including the widely popular Bispecific ...